Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
26-29 March, 2025
Not Confirmed
Not Confirmed
27-29 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
26-29 March, 2025
Industry Trade Show
Not Confirmed
27-29 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
20 Mar 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-health-regulator-clears-use-ai-tool-fatty-liver-disease-trials-2025-03-20/
11 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/11/3040473/0/en/Madrigal-Appoints-Jacqualyn-A-Fouse-Ph-D-to-Its-Board-of-Directors.html
27 Feb 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/launch-metrics-are-tracking-exceptionally-well-madrigals-nash-drug-rezdiffra
26 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/26/3032756/0/en/Madrigal-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Announces-New-Two-Year-Data-Demonstrating-Potential-Benefit-of-Rezdiffra-resmetirom-in-Pati.html
26 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/26/3032712/0/en/Madrigal-Announces-New-Two-Year-Data-from-the-Compensated-MASH-Cirrhosis-Arm-of-the-MAESTRO-NAFLD-1-Trial-Demonstrating-Potential-Benefit-of-Rezdiffra-resmetirom-in-Patients-with-C.html
21 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/21/3030423/0/en/Madrigal-Pharmaceuticals-to-Participate-in-the-45th-Annual-TD-Cowen-Health-Care-Conference.html
ABOUT THIS PAGE